|
|
|
51-200 employees
View all Merrimack Pharmaceuticals employees
|
|
Pharmaceutical
|
|
Cambridge, MA
|
|
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor. Merrimack Pharmaceuticals, Inc. was formerly known as Atlantic BioPharmaceuticals, Inc. The company was founded in 1993 and is based in Cambridge, Massachusetts.
|
The decision makers in Merrimack Pharmaceuticals are Alia Al-beer, Andy Porter, Art Kudla, etc. Click to Find Merrimack Pharmaceuticals decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.